Conceptually, irritant contact dermatitis (irritation) and allergic contact dermatitis (ACD) in man should provide the ideal platforms to launch in vitro toxicology into the pantheon of in vitro testing assays. In theory, irritant dermatitis has been considered by most a simple area of cutaneous biology, whereas ACD is a complex area of biology. However, both result in responses that are reasonably stereotypical and well characterized. The biology of the underlying mechanisms is becoming characterized and will thus allow development of mechanistically based in vitro assays that will be scientifically validated and thus acceptable to regulatory agencies. Environ Health Perspect 106(Suppl 2): 493-496 (1998). http.//eehpnetl.niehs.nih.gov/docs/1998/Suppl-2/493-496goldberg/abstract. html
Toxicology (1) .
For irritancy testing, physical-chemical measurements, quantitative structureactivity relationship (QSAR), and historical data can provide significant data. In vitro methods that measure cytotoxic interleukins (ILs)la, arachidonic acid, and the prostaglandins (1,2) should provide adequate information on acute mild irritants through and including corrosivity. Additionally, reconstituted tissue equivalents (RTE) and skin explants may be useful in other situations.
All these systems are in development or in use in research laboratories. They have not gone through adequate optimization yet to be ready for validation, but one can expect that this will begin to happen in the near future. b) understand the biology of adhesion molecules; c) improve and define the conditions of the biologic systems; and d) establish relationships between these biochemical systems, molecules, and exogenous chemicals.
In evaluating acute toxicants (including dermal), it has been suggested that once data from in vitro testing are evaluated, including what is known about the chemicals and evaluation of these chemicals [e.g., QSAR (3, 4) , literature, physical-chemical measures], it may then be appropriate to establish safety of these materials directly in the human ( Figure 1 ).
Corrosivity, a physical destruction of the skin, is the extreme case of irritancy. It is likely that in the near future we will be able to predict corrosive ability using QSAR, physical and chemical assays, and historical information to fully assess the hazard (3-6). It is inappropriate for us to assess the degree of severe corrosives using either whole animal or human clinical studies.
Phototoxicity
Dermal phototoxicity results from photo-activation of chemicals that cause either a photoirritant or a photoallergic response. A method to examine phototoxicity has recently been described (7, 8) . The developers of this assay suggest that it is validated, but it has not yet been submitted for fully independent, anonymous peer (23) . The cytokines GM-CSF (20, 24) and, to a lesser extent, IL-1 (24) (27) . mRNA can be induced in cultured keratinocytes in response to IL-1oa (26) .
The complexity of the biology, presented alone, provides many opportunities to develop a battery of in vitro tests based on mechanistic understanding (28) (29) (30) (31) (32) (33) .
The potential systems and end points are summarized in Table 2 .
If one uses the schematic in Figure 1 then QSAR, historical data, and literature may provide adequate data to classify a compound or will identify which specific in vitro tests will be appropriate. The next sequential step will be to use cell culture and RTE and measure appropriate cytokines, adhesion molecules, and/or histochemistry.
Needs and Future Direction
Many methods have been evaluated by different laboratories. There is a clear need for additional studies to more completely define and identify the underlying biology of the cytokines, adhesion molecules, and other inflammatory molecules. This knowledge will provide the rationale for specific batteries of in vitro tests to provide measures of irritancy, corrosivity, and allergic potential.
What remains to be done is not only validating the assays for man. This is a needed step, but only after appropriate methods are fully developed to generally accepted standards of scientific rigor using in principle the criteria described by the Interagency Coordinating Committee for the Validation of Alternative Methods (34) and the OECD (35) for validation and regulatory acceptance. Then an understanding of how to use the information appropriately for risk assessment will be the next challenge.
